Biomarin Pharmaceutical
Price & Volume
Stats
See more52W Range | $49.26-$70.98 |
Market Cap | $10.6B |
Shares Short | 11M |
Financials
See moreRevenue (12 Mos) | $3.4B |
Revenue Growth (YoY) | 19.9% |
Gross Profit (12 Mos) | $1.7B |
Diluted EPS | $0.37 |
News
See moreYahoo Finance • 10 days ago
The Strategic Financial Case for BioMarin Pharmaceutical (BMRN)
Yahoo Finance • 13 days ago
3 Healthcare Stocks That Fall Short
Yahoo Finance • 23 days ago
BioMarin Targets Amicus Synergies as VOXZOGO Nears $1B Milestone
Yahoo Finance • 23 days ago
FDA Grants Priority Review to AZN's Filing for Rare Bone Disease Drug
About
CEO | Mr. Alexander Hardy |
CFO | Mr. Brian R. Mueller CPA |
Address | 770 Lindaro Street, San Rafael, CA, United States, 94901 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 3,221 |